MedPath

In Vitro Diagnostic Device for the Detection of Strep A

Completed
Conditions
Streptococcal Sore Throat
Registration Number
NCT02068469
Lead Sponsor
IQuum, Inc.
Brief Summary

The purpose of this trial is to show the accuracy and specificity of the Liat analyzer and assay for detecting Strep A at the point of care lab compared to culture.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
799
Inclusion Criteria
  • Subjects who are 3 years of age or older

  • Subjects exhibiting symptoms characteristic of pharyngitis, possibly Streptococcus A, including:

    • presence of sore throat, and at least one other symptom from the list below:
    • redness of the posterior pharyngeal wall
    • pharyngeal or tonsillar exudate
    • tonsillar swelling
    • tender cervical lymphadenopathy
    • fever, >38C at presentation or within the past 24 hours
  • Subjects who are able to understand and consent to participation; for minors under the age of 18, this includes parent or legal guardian

Exclusion Criteria
  • Subjects treated with antibiotics currently or within the previous 7 days.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluate sensitivity and specificity of the Liat Strep A assay when compared to cultureResults based on samples collected at initial visit
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Twelve Corners Pediatrics

🇺🇸

Rochester, New York, United States

Plano Pediatrics

🇺🇸

Plano, Texas, United States

Advanced Pediatrics

🇺🇸

Vienna, Virginia, United States

Meridian Clinical Research

🇺🇸

Savannah, Georgia, United States

Norwich Pediatrics

🇺🇸

Norwich, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath